Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Eshelman Fredric N
Relationship:   10% Owner
City:   Wilmington
State:   NC
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   8,151,654    

Indirect Shares

   3,933,809      
Direct Value   $81,087,417    

Indirect Value

   $18,355,565      
Total Shares   12,085,463      
Total Value   $99,442,982      


Bausch Health Companies Inc $272,682 G1 Therapeutics Inc $1,162,500 Eyenovia Inc $1,068,230 Liquidia Technologies Inc $78,584,005 Bausch Health Companies Inc $272,682 G1 Therapeutics Inc $1,162,500 Eyenovia Inc $1,068,230 Liquidia Technologies Inc $78,584,005
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    7   
    3    

     Stock price went up :
    0   
    0    
     Stock price went down :
    7   
    3    
   
     Gain/Loss Ratio :
   -7.0   
   -3.0   
     Percentage Gain/Loss :
   -45.7%
 -43.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Pharmaceutical Product Developme... PPDI Executive Chairman, Di... 2011-12-05 0 2011-12-05 0    Premium*  
            Furiex Pharmaceuticals, Inc. FURX Director, 10% Owner 2014-07-02 0 2014-07-02 0    Premium*  
            Bausch Health Companies Inc BHC Director 2017-05-05 38,298 2016-03-11 0    Premium*  
            G1 Therapeutics Inc GTHX Director, 10% Owner 2017-11-13 250,000 2017-11-13 3,439,151    Premium*  
            Eyenovia Inc EYEN Director 2020-09-11 1,292,787 2020-09-11 319,085    Premium*  
            Liquidia Technologies Inc LQDA 10% Owner 2020-11-25 6,570,569 2020-11-25 175,573    Premium*  
* Premium Members only  

Records found :    148         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
LQDA Liquidia Technologies Inc 10% Owner   –       –       •   2019-12-27 3 IO $0.00 $0 D/D 0 5,159,744 -
LQDA Liquidia Technologies Inc 10% Owner   –       –       •   2020-03-30 4 B $4.76 $67,106 I/I 14,100 14,100 1.5 %
LQDA Liquidia Technologies Inc 10% Owner   –       –       •   2020-03-31 4 B $4.87 $146,112 I/I 30,000 44,100 1.5 %
LQDA Liquidia Technologies Inc 10% Owner   –       –       •   2020-04-01 4 B $4.89 $220,122 I/I 45,000 89,100 1.5 %
LQDA Liquidia Technologies Inc 10% Owner   –       –       •   2020-04-02 4 B $4.96 $35,792 I/I 7,223 96,323 1.5 %
LQDA Liquidia Technologies Inc 10% Owner   –       –       •   2020-04-03 4 B $4.85 $169,740 I/I 35,000 131,323 1.5 %
LQDA Liquidia Technologies Inc 10% Owner   –       –       •   2020-04-06 4 B $5.28 $233,715 I/I 44,250 175,573 1.5 %
LQDA Liquidia Technologies Inc 10% Owner   –       –       •   2020-07-02 4 B $8.00 $15,000,000 D/D 1,875,000 7,034,744 2.45 %
LQDA Liquidia Technologies Inc 10% Owner   –       –       •   2020-11-19 4 D $3.35 $100,500 D/D (30,000) 7,004,744 0 -
LQDA Liquidia Technologies Inc 10% Owner   –       –       •   2020-11-23 4 S $3.16 $421,347 D/D (133,346) 6,871,398 0 %
LQDA Liquidia Technologies Inc 10% Owner   –       –       •   2020-11-24 4 S $3.15 $894,247 D/D (283,465) 6,587,933 0 %
LQDA Liquidia Technologies Inc 10% Owner   –       –       •   2020-11-25 4 S $3.13 $54,349 D/D (17,364) 6,570,569 0 %
PPDI Pharmaceutical Product De... CEO   •       •      –    2005-04-04 4 GD $0.00 $0 D/D 7,000 4,957,263 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2005-05-18 4 A $0.00 $0 D/D 25,000 4,982,263 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2005-05-26 4 OE $6.53 $5,706,592 D/D 380,000 5,362,263 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2005-07-20 4 S $59.96 $9,185,899 D/D (153,000) 5,209,263 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2005-07-21 4 S $59.37 $41,500 D/D (699) 5,060,053 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2005-07-21 4 S $59.26 $2,325,274 D/D (38,976) 5,034,811 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2005-07-21 4 S $59.51 $3,401,213 D/D (56,989) 5,152,274 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2005-07-21 4 S $59.40 $4,655,153 D/D (77,788) 5,074,486 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2005-07-22 4 S $59.02 $1,076,796 D/D (17,947) 4,962,263 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2005-07-22 4 S $59.03 $3,250,299 D/D (54,601) 4,980,210 -
PPDI Pharmaceutical Product De... CEO   •       –      –    2006-05-15 4 S $36.45 $7,278,096 D/D (198,425) 9,632,101 0 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2006-05-15 4 S $36.88 $2,016,198 D/D (54,575) 9,577,526 -
PPDI Pharmaceutical Product De... CEO   •       •      –    2006-05-16 4 S $36.07 $2,608,273 D/D (72,045) 9,505,481 -
  148  Records found
  1  2   3   4   5   6      
  Page 1 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us